查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404747

數位治療市場規模、佔有率、趨勢分析報告：按應用、按最終用途、按地區、細分市場預測，2024-2030 年

Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity, Smoking Cessation, Respiratory Diseases), By End-use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

數位治療市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球數位治療市場規模預計將達到325億美元，2024年至2030年複合年成長率為27.2%。

智慧型手機的普及、數位醫療技術對醫療保健提供者和患者的成本效益以及對綜合醫療保健系統和以患者為中心的護理不斷成長的需求是市場的主要推動力。全球化和生活方式的改變，例如吸煙率增加、營養缺乏、缺乏運動和酒精成癮增加，正在增加患慢性病的風險。擁有智慧型手機在增加全球連結方面逐漸變得越來越重要，從而在推動市場擴張方面發揮關鍵作用。

COVID-19 正在成為廣泛採用數位治療解決方案的催化劑。例如，Teladoc 報告稱，與大流行前的水平相比，遠端醫療的使用量增加了 38 倍。 FDA 等有影響力的監管機構採取的支持措施進一步推動了採用率的激增。例如，2020 年 4 月，美國FDA 發布了一份指導方針，旨在擴大為精神疾病患者設計的數位健康治療設備的使用範圍。同時，Kepios資料顯示，全球網路用戶數量年增率為 7.6%，平均每天新增 90 萬新用戶。雖然已開發國家和新興經濟體的智慧型手機和網路普及很高，但非洲和南亞等地區的經濟較不發達，在普及落後。

然而，新興國家對數位療法的認知和理解有限以及患者資料隱私問題等挑戰正在阻礙市場成長。數位療法開發人員和製造商無法保證患者資料的安全性和機密性，導致消費者擔憂。對資料隱私的擔憂是數位療法普及的主要障礙。對資料外洩以及透過科技遭受不必要的個人監視的可能性的擔憂進一步阻礙了市場的成長。

儘管有這些挑戰，數位療法正在成為患有各種疾病的患者的重要治療選擇，這主要歸功於主要行業參與者的個體化治療計劃和策略性舉措。這些努力包括收購、產品核可、產品發布和合作夥伴關係。此外，心臟病、糖尿病和焦慮症等慢性病的盛行率不斷上升，迫使主要市場參與者投資數位治療解決方案。目前許多製造商正在開發專門針對焦慮症的產品，並且有幾種此類產品處於不同的開發階段。這代表著巨大的市場成長機會。

數位治療市場報告亮點

  • 從應用來看，由於市場參與者技術的快速進步，2023年糖尿病領域將佔29.4%的市場佔有率。預計該細分市場在 2024 年至 2030 年的預測期內也將出現最快的成長。
  • 由於患有慢性病的患者數量不斷增加，2023年患者細分市場佔據最大市場佔有率，達到33.7%。數位療法還可以幫助改善治療的可及性，特別是對於農村和偏遠地區的人們。
  • 由於對數位療法的高需求，北美將在 2023 年佔據市場主導地位。由於醫療保健意識的提高和數位健康產品的使用增加，預計這些區域市場在預測期內將表現出類似的趨勢。
  • 2023 年 1 月，Omada Health 與 Intermountain Healthcare 的子公司 Castell 合作，擴大 Intermountain Healthcare 猶他醫療集團內患者獲得糖尿病預防計畫的機會。 Castell 將透過現有的護理途徑識別和招募符合條件的患者，並提案護理協調員和提供者參與 Omada 的計劃。
  • 2022 年 9 月，Limbix Health 與洛杉磯兒童醫院 (CHLA) 合作推出了 SparkRx，這是一種自我管理的數位治療方法，專為特定醫療機構中有憂鬱症徵兆的青少年（13-22 歲）而設計。我進行了調查。 SparkRx 專注於認知行為療法 (CBT)，透過應對策略指導幫助青少年識別和管理憂鬱症。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章 數位治療的變數、趨勢與範圍

  • 市場體系展望
    • 母市場分析
    • 附隨市場前景
  • 市場動態
    • 市場促進因素分析
    • 慢性病盛行率增加
    • 已開發國家和新興國家智慧型手機普及不斷提高
    • 數位醫療技術對醫療保健專業人員和患者的成本效益
    • 對綜合醫療保健系統和以患者為中心的護理的需求不斷成長
    • 市場抑制因素分析
    • 資料保護和隱私問題
    • 某些市場相關人員不願意採用
    • 波特五力分析
    • 新進入者的威脅：低
    • 競爭公司之間的敵意：高
    • 替代品威脅：低
    • 買方議價能力：高
    • 供應商議價能力：低
    • PESTLE分析
    • 政治和法律
    • 經濟和社會
    • 技術的
  • COVID-19 對數位療法的影響

第 4 章 數位化治療市場：使用量估算與趨勢分析

  • 數位治療市場：應用變化分析
  • 市場定義和範圍
  • 按用途
  • 糖尿病
  • 肥胖
  • CVD
    • 禁止抽煙
  • 中樞神經系統疾病
  • 其他

第5章數位治療市場：最終用途估計與趨勢分析

  • 數位治療市場：最終用途變異分析
  • 市場定義和範圍
  • 按最終用途
  • 病人
  • 提供者
  • 付款人
  • 雇主
  • 其他最終用途

第 6 章 數位治療：按應用和最終用途分類的區域估計和趨勢分析

  • 北美洲
    • 競爭場景
    • 2018-2030 年北美數位治療市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 競爭場景
    • 2018-2030 年歐洲數位治療市場估計與預測
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 競爭場景
    • 2018-2030 年亞太地區數位治療市場估計與預測
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 競爭場景
    • 2018-2030 年拉丁美洲數位治療市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 競爭場景
    • 中東和非洲數位治療市場估計和預測，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 科威特

第7章競爭分析

  • 熱圖分析
  • 參與企業
    • 公司分類分析

第8章 公司簡介

  • OMADA Health, Inc.
  • Welldoc, Inc.
  • 2Morrow, Inc.
  • Teladoc Health, Inc.
  • Propeller Health
  • CANARY HEALTH
  • Noom, Inc.
  • Fitbit, LLC
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc.
  • HYGIEIA
  • DarioHealth, Corp.
  • GAIA AG
  • BigHealth
  • Limbix Health, Inc.
  • 玩家採用的主要策略是：
    • 擴張
    • 獲得
    • 合作
    • 其他
Product Code: GVR-1-68038-768-1

Digital Therapeutics Market Growth & Trends:

The global digital therapeutics market size is expected to reach USD 32.5 billion by 2030, exhibiting a CAGR of 27.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising adoption of smartphones, cost-effectiveness of digital health technology for healthcare providers and patients, and growing demand for integrated healthcare systems and patient-centered care primarily drive the market. Globalization and changing lifestyles, such as increased prevalence of smoking, poor nutrition, lack of exercise, and increased alcoholism, increases the risk of developing chronic diseases. Possessing a smartphone is progressively gaining significance in enhancing global connectivity, thereby playing a crucial role in propelling market expansion.

COVID-19 has acted as a catalyst for widespread adoption of digital therapeutics solutions. Teladoc, for example, reported a staggering 38-fold increase in telehealth usage compared to pre-pandemic levels. This surge in adoption was further bolstered by supportive measures implemented by influential regulatory bodies such as the FDA. An instance is issuance of guidelines by the U.S. FDA in April 2020 aimed at broadening the accessibility of digital health therapeutic devices designed for individuals with psychiatric conditions. In line with this, Kepios data reveals a global annual growth rate of 7.6% in number of internet users, equating to an average daily addition of 900,000 new users. Although developed and developing economies have achieved high smartphone and internet penetration, regions such as Africa and South Asia are experiencing slower progress due to their less advanced economies.

However, growth of the market is being impeded by challenges such as limited awareness and understanding of digital therapies in developing countries and concerns regarding patient data privacy. Developers and manufacturers of digital therapeutics have not been able to assure the security and confidentiality of patient data, leading to consumer apprehension. This fear regarding data privacy is a significant barrier to the widespread adoption of digital therapeutics. Concerns about data breaches and potential exposure to unwanted personal surveillance through technology further hinder market growth.

Despite these challenges, digital therapeutics has emerged as a crucial treatment option for patients with various medical conditions, primarily due to personalized treatment programs and the strategic initiatives taken by key industry players. These initiatives involve acquisitions, product approvals, product launches, and partnerships. Furthermore, the increasing prevalence of chronic diseases like heart disease, diabetes, and anxiety disorders has compelled major market players to invest in digital treatment solutions. Currently, numerous manufacturers are developing products specifically targeting anxiety disorders, and several such products are at different stages of development. This presents a significant opportunity for market growth.

Digital Therapeutics Market Report Highlights:

  • Based on application, the diabetes segment held the market share of 29.4% in 2023 owing to rapid technological advancements by market players. The segment is also expected to witness the fastest growth over the forecast period from 2024 to 2030
  • The patients segment held the largest market share of 33.7% in 2023, owing to the growing number of patients suffering from chronic conditions. Digital therapeutics can also help improve access to care for people, especially those from rural and remote areas
  • North America dominated the market in 2023 owing to the high demand for digital therapeutics in the region. These regional marketplaces are expected to show similar trends throughout the forecast period due to rising healthcare awareness coupled with increased use of digital health products over the forecast period
  • In January 2023, Omada Health partnered with Castell, an Intermountain Healthcare subsidiary, to expand access to its diabetes prevention program for patients under Intermountain Healthcare's Utah Medical Group. Castell will identify and enroll eligible patients through existing care pathways, with care coordinators and providers reaching out to offer participation in Omada programs
  • In September 2022, Limbix Health partnered with Children's Hospital Los Angeles (CHLA) to research SparkRx, a self-directed digital treatment designed for adolescents (ages 13-22) with signs of depression in specific medical care settings. SparkRx, centered on Cognitive Behavioral Therapy (CBT), assists teens in recognizing and managing depression through the teaching of coping mechanisms

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
  • 1.2 Research Process
    • 1.2.1 Information Procurement
  • 1.3 Research Scope and Assumptions
  • 1.4 Research Methodology
  • 1.5 Objectives
    • 1.5.1 Objective - 1
    • 1.5.2 Objective - 2
    • 1.5.3 Objective - 3
  • 1.6 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Executive Summary
  • 2.2 Digital Therapeutics Snapshot
  • 2.3 Digital Therapeutics Segment Snapshot
  • 2.4 Digital Therapeutics Competitive Landscape Snapshot

Chapter 3 Digital Therapeutics Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market analysis
    • 3.1.2 Ancillary market outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.3 Increasing prevalence of chronic diseases
    • 3.2.4 Increasing smartphone penetration in developed and developing countries
    • 3.2.5 Cost-effectiveness of digital health technology for providers and patients
    • 3.2.6 Increasing demand for integrated healthcare systems and patient-centric care
    • 3.2.5 Market Restraint Analysis
    • 3.2.6 Concerns over data protection & privacy
    • 3.2.7 Reluctance in adoption by certain market stakeholders
    • 3.2.7 Porter Five Force Analysis
    • 3.2.8 Threat of New Entrants: Low
    • 3.2.9 Competitive Rivalry: High
    • 3.2.10 Threat of Substitutes: Low
    • 3.2.11 Bargaining Power of Buyers: High
    • 3.2.12 Bargaining Power of Suppliers: Low
    • 3.2.13 Pestle Analysis
    • 3.2.14 Political and legal
    • 3.2.15 Economical & Social
    • 3.2.16 Technological
  • 3.3 Impact of COVID-19 on the Digital Therapeutics

Chapter 4 Digital Therapeutics Market: Application Estimates & Trend Analysis

  • 4.1 Digital Therapeutics Market: Application Movement Analysis
  • 4.2 Market Definition and Scope
  • 4.3 Digital Therapeutics Market Estimates & Forecast, By Application (USD Million)
  • 4.4 Diabetes
  • 4.5 Obesity
  • 4.6 CVD
      • 4.7Smoking Cessation
  • 4.8 CNS Diseases
  • 4.9 OTHERS

Chapter 5 Digital Therapeutics Market: End-Use Estimates & Trend Analysis

  • 5.1 Digital Therapeutics Market: End-Use Movement Analysis
  • 5.2 Market Definition and Scope
  • 5.3 Digital Therapeutics Market Estimates & Forecast, By End-Use (USD Million)
  • 5.4 Patients
  • 5.5 Providers
  • 5.6 Payers
  • 5.7 Employers
  • 5.8 Other End-uses

Chapter 6 Digital Therapeutics: Regional Estimates & Trend Analysis, by Application, and End-Use

  • 6.1 North America
    • 6.1.1 Competitive Scenario
    • 6.1.2 North America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million):
    • 6.1.3 U.S.
      • 6.1.3.1 Key Country Dynamics
      • 6.1.3.2 Regulatory framework
      • 6.1.3.3 U.S. Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.1.4 Canada
      • 6.1.4.1 Key Country Dynamics
      • 6.1.4.2 Regulatory framework
      • 6.1.4.3 Canada Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.2 Europe
    • 6.2.1 Competitive Scenario
    • 6.2.2 Europe Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3 UK
      • 6.2.3.1 Key Country Dynamics
      • 6.2.3.2 Regulatory framework
      • 6.2.3.3 UK Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4 Germany
      • 6.2.4.1 Key Country Dynamics
      • 6.2.4.2 Regulatory framework
      • 6.2.4.3 Germany Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5 France
      • 6.2.5.1 Key Country Dynamics
      • 6.2.5.2 Regulatory framework
      • 6.2.5.3 France Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6 Spain
      • 6.2.6.1 Key Country Dynamics
      • 6.2.6.2 Regulatory framework
      • 6.2.6.3 Spain Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7 Italy
      • 6.2.7.1 Key Country Dynamics
      • 6.2.7.2 Regulatory framework
      • 6.2.7.2 Italy Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.8 Denmark
      • 6.2.8.1 Key Country Dynamics
      • 6.2.8.2 Regulatory framework
      • 6.2.8.3 Denmark Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.9 Sweden
      • 6.2.9.1 Key Country Dynamics
      • 6.2.9.2 Regulatory framework
      • 6.2.9.3 Sweden Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.10 Norway
      • 6.2.10.1 Key Country Dynamics
      • 6.2.10.2 Regulatory framework
      • 6.2.10.3 Norway Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.3 Asia Pacific
    • 6.3.1 Competitive Scenario
    • 6.3.2 Asia Pacific Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Japan
      • 6.3.3.1 Key Country Dynamics
      • 6.3.3.2 Regulatory framework
      • 6.3.3.3 Japan Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4 China
      • 6.3.4.1 Key Country Dynamics
      • 6.3.4.2 Regulatory framework
      • 6.3.4.3 China Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5 India
      • 6.3.5.1 Key Country Dynamics
      • 6.3.5.2 Regulatory framework
      • 6.3.5.3 India Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6 Australia
      • 6.3.6.1 Key Country Dynamics
      • 6.3.6.2 Regulatory framework
      • 6.3.6.3 Australia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7 South korea
      • 6.3.7.1 Key Country Dynamics
      • 6.3.7.2 Regulatory framework
      • 6.3.7.3 South korea Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8 Thailand
      • 6.3.8.1 Key Country Dynamics
      • 6.3.8.2 Regulatory framework
      • 6.3.8.3 ThailandDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Latin America
    • 6.4.1 Competitive Scenario:
    • 6.4.2 Latin America Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Brazil
      • 6.4.3.1 Key Country Dynamics
      • 6.4.3.2 Regulatory framework
      • 6.4.3.3 BrazilDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 Mexico
      • 6.4.4.1 Key Country Dynamics
      • 6.4.4.2 Regulatory framework
      • 6.4.4.3 MexicoDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Argentina
      • 6.4.5.1 Key Country Dynamics
      • 6.4.5.2 Regulatory framework
      • 6.4.5.2 Argentina Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 MEA
    • 6.5.1 COMPETITIVE SCENARIO
    • 6.5.2 MEA Digital Therapeutics Market Estimates And ForecastsS, 2018 - 2030 (USD Million)
    • 6.5.3 South Africa
      • 6.5.3.1 Key Country Dynamics
      • 6.5.3.2 Regulatory framework
      • 6.5.3.3 South Africa Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4 Saudi arabia
      • 6.5.4.1 Key Country Dynamics
      • 6.5.4.2 Regulatory framework
      • 6.5.4.3 Saudi arabia Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5 UAE
      • 6.5.5.1 Key Country Dynamics
      • 6.5.5.2 Regulatory framework
      • 6.5.5.3 UAE Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6 Israel
      • 6.5.6.1 Key Country Dynamics
      • 6.5.6.2 Regulatory framework
      • 6.5.6.3 Israel Digital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7 Kuwait
      • 6.5.7.1 Key Country Dynamics
      • 6.5.7.2 Regulatory framework
      • 6.5.7.3 KuwaitDigital Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Analysis

  • 7.1 Heat Map Analysis
  • 7.2 Participant Categorization
    • 7.2.1 Company Categorization Analysis

Chapter 8 Company Profile

  • 8.1. OMADA Health, Inc.
  • 8.2. Welldoc, Inc.
  • 8.3. 2Morrow, Inc.
  • 8.4. Teladoc Health, Inc.
  • 8.5. Propeller Health
  • 8.6. CANARY HEALTH
  • 8.7. Noom, Inc.
  • 8.8. Fitbit, LLC
  • 8.9. Pear Therapeutics, Inc.
  • 8.10. Akili Interactive Labs, Inc.
  • 8.11. HYGIEIA
  • 8.12. DarioHealth, Corp.
  • 8.13. GAIA AG
  • 8.14. BigHealth
  • 8.15. Limbix Health, Inc.
  • 8.16 Key Strategies Adopted by Players Include:
    • 8.16.1 Expansion
    • 8.16.2 Acquisition
    • 8.16.3 Collaborations
    • 8.16.4 Others 

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of abbreviation
  • TABLE 3 North America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 4 North America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 5 North America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 7 U.S. macro dynamics
  • TABLE 8 U.S. digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 9 U.S. digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 10 Canada macro dynamics
  • TABLE 11 Canada digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 12 Canada digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 13 Europe digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 14 Europe digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 15 Europe digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 16 UK macro dynamics
  • TABLE 17 UK digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 18 UK digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 Germany macro dynamics
  • TABLE 20 Germany digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 21 Germany digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 22 France macro dynamics
  • TABLE 23 France digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 24 France digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 25 Italy macro dynamics
  • TABLE 26 Italy digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 27 Italy digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Spain macro dynamics
  • TABLE 29 Spain digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 30 Spain digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 31 Denmark macro dynamics
  • TABLE 32 Denmark digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 33 Denmark digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Sweden macro dynamics
  • TABLE 35 Sweden digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 36 Sweden digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 37 Norway macro dynamics
  • TABLE 38 Norway digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 39 Norway digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 40 Asia Pacific digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 41 Asia Pacific digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 42 Asia Pacific digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 Asia Pacific digital therapeutics market estimates and forecasts, by therapeutic application, 2018 - 2030 (USD Million)
  • TABLE 44 Japan macro dynamics
  • TABLE 45 Japan digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 46 Japan digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 China macro dynamics
  • TABLE 48 China digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 49 China digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 50 India macro dynamics
  • TABLE 51 India digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 52 India digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 53 Australia Macro dynamics
  • TABLE 54 Australia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 55 Australia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Thailand macro dynamics
  • TABLE 57 Thailand digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 58 Thailand digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 59 South Korea macro dynamics
  • TABLE 60 South Korea digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 61 South Korea digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 62 Latin America digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 63 Latin America digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Latin America digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 65 Brazil macro dynamics
  • TABLE 66 Brazil digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 67 Brazil digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 68 Mexico macro dynamics
  • TABLE 69 Mexico digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 70 Mexico digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 71 Argentina macro dynamics
  • TABLE 72 Argentina digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 73 Argentina digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 74 MEA digital therapeutics market estimates and forecasts, by country, 2018 - 2030 (USD Million)
  • TABLE 75 MEA digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 76 MEA digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 77 South Africa macro dynamics
  • TABLE 78 South Africa digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 79 South Africa digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 80 Saudi Arabia Macro dynamics
  • TABLE 81 Saudi Arabia digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 82 Saudi Arabia digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 83 UAE Macro dynamics
  • TABLE 84 UAE digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 85 UAE digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 86 Israel Macro dynamics
  • TABLE 87 Israel digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 88 Israel digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 89 Kuwait Macro dynamics
  • TABLE 90 Kuwait digital therapeutics market estimates and forecasts, by application, 2018 - 2030 (USD Million)
  • TABLE 91 Kuwait digital therapeutics market estimates and forecasts, by end-use, 2018 - 2030 (USD Million)
  • TABLE 92 Key companies undertaking expansions
  • TABLE 93 Key companies undertaking acquisitions
  • TABLE 94 Key companies undertaking collaborations

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Estimation methodology
  • FIG. 4 Data triangulation techniques
  • FIG. 5 Primary research pattern
  • FIG. 6 Market research approaches
  • FIG. 7 Value-chain-based sizing & forecasting
  • FIG. 8 QFD modeling for market share assessment
  • FIG. 9 Market formulation & validation
  • FIG. 10 Commodity flow analysis
  • FIG. 11 Digital therapeutics market snapshot, 2023 (USD Million)
  • FIG. 12 Segment snapshot
  • FIG. 13 Competitive landscape snapshot
  • FIG. 14 Parent market outlook
  • FIG. 15 Ancillary market outlook
  • FIG. 16 Digital Therapeutics market dynamics
  • FIG. 17 Digital therapeutics market driver impact
  • FIG. 18 Annual cost per person (USD) for key chronic conditions & by no. of co-morbidities
  • FIG. 19 Top countries by smartphone users, 2021
  • FIG. 20 Digital therapeutics market restraint impact
  • FIG. 21 Market participation categorization
  • FIG. 22 Market leaders and innovators
  • FIG. 23 Company market position analysis
  • FIG. 24 Major deals & strategic alliances analysis
  • FIG. 25 COVID-19 confirmed cases around the world (March 2020- October 2021)
  • FIG. 26 Digital therapeutics market: Application movement analysis
  • FIG. 27 Digital therapeutics Market: Application dashboard
  • FIG. 28 Global diabetes market, 2018 - 2030 (USD Million)
  • FIG. 29 Global obesity market, 2018- 2030 (USD Million)
  • FIG. 30 Global CVD market, 2018- 2030 (USD Million)
  • FIG. 31 Global respiratory diseases market, 2018 - 2030 (USD Million)
  • FIG. 32 Global smoking cessation market, 2018 - 2030 (USD Million)
  • FIG. 33 Global CNS diseases market, 2018- 2030 (USD Million)
  • FIG. 34 Global others market, 2018- 2030 (USD Million)
  • FIG. 35 Digital therapeutics market: End-use movement analysis
  • FIG. 36 Digital therapeutics market: End-use dashboard
  • FIG. 37 Global patients market, 2018- 2030 (USD Million)
  • FIG. 38 Global providers market, 2018 - 2030 (USD Million)
  • FIG. 39 Global payers market, 2018 - 2030 (USD Million)
  • FIG. 40 Global employers market, 2018 - 2030 (USD Million)
  • FIG. 41 Global other end-user market, 2018- 2030 (USD Million)
  • FIG. 42 Regional marketplace: Key takeaways
  • FIG. 43 North America: SWOT analysis
  • FIG. 44 North America digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 45 U.S. digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 46 Canada digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 47 Europe: SWOT analysis
  • FIG. 48 Europe digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 49 UK digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 50 Germany digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 51 France digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 52 Italy digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 53 Spain digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 54 Sweden digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 55 Norway digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 56 Denmark digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 57 Asia Pacific: SWOT analysis
  • FIG. 58 Asia Pacific Digital Therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 59 Japan digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 60 China digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 61 India digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 62 Australia digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 63 South Korea digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • FIG. 64 Thailand digital therapeutics market estimates and forecasts, 2016 - 2030 (USD Million)
  • FIG. 65 Latin America: SWOT analysis
  • FIG. 66 Latin America digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 67 Mexico digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 68 Brazil digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 69 Argentina digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 70 Middle East and Africa: SWOT analysis
  • FIG. 71 Middle East and Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 72 South Africa digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 73 Saudi Arabia digital therapeutics market, 2018 - 2030 (USD Million)
  • FIG. 74 UAE digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 75 Israel digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 76 Kuwait digital therapeutics market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • FIG. 77 Heat map analysis
  • FIG. 78 List of key emerging companies/technology disruptors/innovators